Application of cost control and clinical path in perioperative period of breast cancer
10.3760/cma.j.issn.1674-2907.2011.07.005
- VernacularTitle:成本控制与临床路径管理在乳腺癌围手术期的应用
- Author:
Shu-Fen SONG
1
;
Xiao-Jia SHE
;
Qiao-Ru XUE
;
Hai-Yan SHENG
;
Qi QIN
;
Xian-Ming WANG
Author Information
1. 深圳大学附属第一医院(深圳市第二人民医院)
- Keywords:
Breast cancer;
Perioperative period;
Clinical paths;
Cost control
- From:
Chinese Journal of Modern Nursing
2011;17(7):758-760
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the meaning and importance of the implementation of diagnosis related groups ( DRGS) based costs control and clinical path management in breast cancer patients undertaking modified radical mastectomy. Methods 62 patients undertook modified radical mastectomy from February to August in 2009 were in control group; 62 patients undertook modified radical mastectomy with the implementation of diagnosis related groups based costs control and clinical path management were in experimental group; To compare the differences of the average hospitaiization days、average hospitalization fees and patients satisfaction between the two groups. Results There were statistical significances in the average hospitalization days、average hospitalization fees and patients satisfaction between the two groups ( P < 0. 05 ). Conclusions The implementation of diagnosis related groups based costs control and clinical path management in breast cancer patients undertook modified radical mastectomy can make a obvious promotion in continuous quality improvement, shorten the average hospitalization days, reduce the medical costs, increase patients satisfaction,and it is worth popularizing.
